# Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes

> **NCT05185518** · NA · UNKNOWN · sponsor: **Pacific Diabetes Technologies** · enrollment: 18 (estimated)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** Use of novel insulin injection port

## Key facts

- **NCT ID:** NCT05185518
- **Lead sponsor:** Pacific Diabetes Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2025-09
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05185518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05185518, "Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05185518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*